Navigation Links
Drug May Ease Angina in People With Type 2 Diabetes
Date:3/10/2013

can College of Cardiology and will appear in the journal's May 21 print issue.

The study was funded by Gilead Sciences, Inc., which makes Ranexa.

"Angina is associated with worse quality of life, increased risk of hospitalization and higher health care costs, and appears to be more prevalent in patients with diabetes," study lead author Dr. Mikhail Kosiborod, associate professor of medicine at the University of Missouri, Kansas City, and a cardiologist at St. Luke's Mid America Heart Institute, said in a meeting news release.

"While ranolazine was shown to be effective in reducing angina in prior studies, this is the first time it has been prospectively evaluated in patients with diabetes -- a high-risk and therapeutically challenging group," he added.

The study also found that Ranexa had the strongest effect in reducing angina episodes among patients with poor blood sugar control. Prior research has shown that the drug may lower fasting glucose levels in people with diabetes.

"Ranolazine is an effective anti-anginal drug in patients with diabetes and may also have a glucose [blood sugar]-lowering effect," Kosiborod said. "If the glucose-lowering action of ranolazine is confirmed in future studies, patients with diabetes and angina may derive a dual benefit from this drug."

Weintraub agreed. "As the focus of the treatment of angina in diabetics increasingly focuses on [drug] therapy, this may offer another choice in optimal medical care in this group of patients," he said.

The majority of the study patients were men (61 percent). Ninety-six percent had high blood pressure and 74 percent had a history of heart attack. Most patients were taking cholesterol-lowering statins (82 percent) and heart drugs such as ACE inhibitors (88 percent). Sixteen percent were smokers.

About 347 million people worldwide have diabetes and about 90 percent of those people have type 2 diabetes. The main causes of type 2 diabetes are belie
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Enzyme explains angina in diabetics
2. Normal triglyceride levels in people of African descent may hinder diagnosis of metabolic syndrome
3. Anxiety Might Help People Sniff Out Threats
4. People Carrying Guns May Appear Bigger Than They Are
5. CT Scans Deliver More Radiation to Obese People: Study
6. Good intentions bring mixed results for Haitis disabled people
7. Migraines More Likely for People With Celiac Disease, Study Says
8. People Love Talking About Themselves, Brain Scans Show
9. Older People With Dementia Cared for Mostly at Home
10. People With HIV at Higher Odds of Sudden Cardiac Death
11. People Who Lived Near World Trade Center Report More Lung Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Ease Angina in People With Type 2 Diabetes
(Date:8/30/2014)... Dallas, TX (PRWEB) August 30, 2014 ... Cell Disruptor Industry, 2009-2019 is a professional and ... Disruptor industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, Production value, and market ...
(Date:8/30/2014)... Hundreds of Byetta lawsuits ( http://www.byettalawsuit.com ... forward in U.S. courts, Bernstein Liebhard LLP reports. According ... 31, 2014, Byetta and Bydureon (an extended-release version of ... that allege the drugs caused pancreatitis, pancreatic cancer and ... claims are pending in a multidistrict litigation underway in ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Continuing to ... Dermatology is expanding with the addition of a new ... Hammond who has provided leading-edge skin care in Grand ... Dermatology. , “As a doctor, my passion is ... Through partnering with Forefront Dermatology, I’m better able to ...
(Date:8/30/2014)... 2014 In today’s world, a good night’s ... Snoring and sleep apnea (a medical problem where the airway ... bed partners of the rest they need to face their ... snores and 20 million people in the United States alone ... and treated; and of those treated, many cannot tolerate their ...
(Date:8/30/2014)... "My wife suffered neck, back and spine ... one of two inventors from Bethel, Alaska. "The whiplash ... neck area. She tried other pillows to little avail. ... in comfort and providing extra sleep." , They created ... the head, neck and back comfortably. This enables the ...
Breaking Medicine News(10 mins):Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 3Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 4Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Expanding Care at the Forefront of Dermatology 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... To Follow Along Online, WICHITA, Kan., May 22 ... top of the world -- Mount Everest -- that ... Climb another,mountain? How about climb to the highest point ... in 50 days or less., (Photo: http://www.newscom.com/cgi-bin/prnh/20080522/AQTH080LOGO ...
... The 39th gathering of the Texas Annual,Conference of the ... to help celebrate the success of the Nothing But ... and,Cote d,Ivoire (Ivory Coast). The Woodlands UMC will host ... reading and signing on May 28 at 10:45 a.m., ...
... colleagues, at Weill Medical College of Cornell University, New York, ... shed doubt on the recently proposed designation of the protein ... a term given to the small number of cells within ... give rise to a new tumor and that therefore are ...
... rates or other outcomes was found between a group ... dialysis and another group that received a more standard ... Veterans Affairs (VA) and National Institutes of Health (NIH) ... England Journal of Medicine. Acute kidney injury, also called ...
... Corporation,(Nasdaq: CRGN ) announced today the completion ... the Company sold the 5,000,000 shares of,TopoTarget common ... for the,sale of CuraGen,s ownership in belinostat. After ... "We are pleased to announce the planned, ...
... for those seeking ... ... Board (PTCB) announced today that over 300,000 pharmacy,technicians have officially ... Pharmacy Technician,Certification Examination or transfer process since the program,s inception,in ...
Cached Medicine News:Health News:Denver Schoolteacher to Climb Summits of 50 States in 50 Days 2Health News:Denver Schoolteacher to Climb Summits of 50 States in 50 Days 3Health News:Local Methodists Host West African Choir, South African Leader at Historic Conference 2Health News:More intensive dialysis does not improve outcomes among patients with acute kidney injury 2Health News:CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million 2Health News:CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million 3Health News:Pharmacy Technician Certification Board (PTCB) Announces Milestone: 300,000 Certified Pharmacy Technicians (CPhT) 2Health News:Pharmacy Technician Certification Board (PTCB) Announces Milestone: 300,000 Certified Pharmacy Technicians (CPhT) 3
(Date:8/29/2014)... Aug. 29, 2014  Unilife Corporation ("Unilife" or "Company") ... that it intends to release its financial results for ... 30, 2014 after market trading ends on Tuesday, September ... conference call for 4:30 p.m. U.S. EDT on Tuesday, ... a.m. AEST), to review the Company,s financial results, commercial partnerships, ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Multiple Sclerosis Drugs Market 2014-2018" report to their ... inflammatory medical condition that results in demyelination, axonal transection, ... an abnormal response by the immune system, which targets ... a potentially debilitating disease in which the damage of ...
(Date:8/29/2014)... UNION CITY, Calif. , Aug. 29, 2014 /PRNewswire/ ... products company manufacturing point-of-care blood instrumentation and consumables to ... Clint Severson , Chairman and Chief Executive Officer, ... Annual Best Ideas Conference 2014 on Tuesday, September 9, ... held at the Omni Berkshire Place Hotel in ...
Breaking Medicine Technology:Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... Novavax, Inc. (Nasdaq: NVAX ) announced today ... its virus-like-particle (VLP) H1N1 influenza vaccine in Mexico in ... Avimex distributes biological and pharmaceutical products for use in ... world. Avimex is providing financial support for the ...
... , SHENYANG, China, Oct. 20 ... "Company"), a leading China-based biotechnology,company focused on researching, developing, ... its annual general,meeting of shareholders held on October 12, ... the Company,s shareholders re-elected Dr. Jing Lou and Mr.,Moujia ...
Cached Medicine Technology:Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5
Stainless steel tray for sterilizing instruments....
For sterilizing, carrying and storage of a Storz diamond knife and barrel gauge....
Diamond knife tray with silicone inserts to securely hold the diamond knife....
Diamond knife tray with silicone inserts to securely hold the diamond knife....
Medicine Products: